Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
HIV/AIDS Resource Center for Women
Michelle Lopez Alora Gale Precious Jackson Nina Martinez Gracia Violeta Ross Quiroga Loreen Willenberg  
Michelle Alora Precious Nina Gracia Loreen  

A Timeline of Women Living With HIV: Past, Present and Future -- 2003

June 2012

2003. The National Institutes of Health releases the press statement titled, "Nevirapine Sustains Advantage Over AZT During Breastfeeding Period." The press release goes on to describe how infants who receive a single does of the inexpensive drug nevirapine soon after birth -- and whose mothers took one dose of the same drug during labor -- were 41 percent less likely to acquire HIV at birth or during breastfeeding than infants in infant/mother pairs who were treated with a multi-dose regimen using AZT. Anthony Fauci states, "This landmark study could have far-reaching implications in resource-poor countries where breastfeeding and mother-to-child HIV transmission are both common."


Sister Mary Elizabeth, a transgender nun and founder of the Web site AEGiS, receives an award at the event Honoring Our Heroes 2003 in Chicago.


The global epidemic crosses a significant threshold when, for the first time, according to new statistics, half of those living with HIV are women.





This article was provided by Terri Wilder. It is a part of the publication A Timeline of Women Living With HIV: Past, Present and Future.
 



Copyright © 2007-2014 Remedy Health Media, LLC. All rights reserved.
See Also
Newly Diagnosed? Here's Advice from HIV-Positive Women
Newly Diagnosed? Get Advice from HIV-Positive Women
What Did You Expect While You Were Expecting?
What Did You Expect While You Were Expecting?
Tools
TheBody.com App
My Health Tracker
Medication and Health Reminders
Assess Your Risk for HIV

Follow Us: Facebook, Twitter, RSS

U.S. ASO Finder